Jonathan Bayne Coulter, Ph.D., M.H.S.

Headshot of Jonathan Bayne Coulter
  • Assistant Professor of Urology

Research Interests

Prostate Cancer; BAF Complex; Hormone Receptors; Radiation; Epigenetics more


Jonathan B. Coulter, PhD, MHS is an Assistant Professor of Urology and member of the Prostate Cancer Program at the Sidney Kimmel Comprehensive Cancer Center. Dr. Coulter received a Ph.D in Molecular and Translational Toxicology from the Johns Hopkins Bloomberg School of Public Health. He then trained as a postdoctoral fellow in prostate cancer research in the Department of Radiation Oncology and Molecular Radiation Sciences at the Johns Hopkins School of Medicine.

His research is directed toward understanding how prostate cancer cells coordinate chromatin remodeling complexes with hormone receptor signaling in order to uncover novel targets and treatment paradigms for lethal cancers. more


  • Assistant Professor of Urology
  • Assistant Professor of Oncology
  • Assistant Professor of Radiation Oncology and Molecular Radiation Sciences

Departments / Divisions



  • B.S.; James Madison University (Virginia) (2004)
  • M.H.S.; Johns Hopkins Bloomberg School of Public Health (Maryland) (2009)
  • Ph.D.; Johns Hopkins Bloomberg School of Public Health (Maryland) (2014)

Research & Publications

Selected Publications

View all on PubMed

Oei AL, Korangath P, Mulka K, Helenius M, Coulter JB, Stewart J, Velarde E, Crezee J, Simons B, Stalpers LJA, Kok HP, Gabrielson K, Franken NAP, and Ivkov R. Enhancing the abscopal effect of radiation and immune checkpoint inhibitor therapies with magnetic nanoparticle hyperthermia in a model of metastatic breast cancer. International Journal of Hyperthermia, 36:sup1, 47-63, [Online 03 Dec 2019].

Kuhns KJ, Lopez-Bertoni H, Coulter JB, Bressler JP. TET1 regulates DNA repair in human glial cells. Toxicology and Applied Pharmacology. 2019 Jul 3;380:114646. PMID: 31278917

Coulter JB*, Lopez-Bertoni H, Kuhns KJ, Lee RS, Laterra J, Bressler JP. TET1 deficiency attenuates the DNA damage response and promotes resistance to DNA damaging agents. Epigenetics. 2017;12(10):854-864. doi: 10.1080/15592294.2017.1359452. Epub 2017 Nov 27. PMID: 28758831   *Corresponding author 

Hedayati M, Haffner MC, Coulter JB*, Raval RR, Zhang Y, Zhou H, Mian O, Knight EJ, Razavi N, Dalrymple S, Isaacs JT, Santos A, Hales R, Nelson WG, Yegnasubramanian S, DeWeese TL. Androgen Deprivation Followed by Acute Androgen Stimulation Selectively Sensitizes AR-Positive Prostate Cancer Cells to Ionizing Radiation. Clinical Cancer Research. 2016 Jul 1;22(13):3310-3319.  PMID: 26831716    *Co-first author 

Activities & Honors


  • Honorable Mention, Bern Schwetz Student Travel Award. National Capital Area Regional Chapter of Society of Toxicology Annual Meeting, San Francisco, CA, 2012
  • 2nd Place, Bern Schwetz Student Travel Award. National Capital Area Regional Chapter of Society of Toxicology. Annual Meeting, San Antonio, TX, 2013
  • Honorable Mention, Johns Hopkins 10th Annual Prostate Research Day Poster Session, 2015
  • The Honorable Ralph Burnett Award for Translational Research, Johns Hopkins 11th Prostate Research Day, 2016
  • First Place Presentation, Johns Hopkins Annual Radiation Oncology Scientific Retreat 2018 Honorable Mention in Translational Research, Sidney Kimmel Comprehensive Cancer Center Fellows Research Day, 2017
  • The Honorable Ralph Burnett Award for Translational Research, Johns Hopkins Donald S. Coffey Prostate Research Day 2019 Scholar in Training Travel Award to the University of Rochester Radiogenomics Consortium from the Radiation Research Society., 2018


  • American Society for Radiation Oncology (ASTRO)
  • American Association for Cancer Research (AACR)
  • Radiation Research Society
  • Physicians for Social Responsibility, Emerging Leaders Council

Patient Ratings & Comments

The Patient Rating score is an average of all responses to physician related questions on the national CG-CAHPS Medical Practice patient experience survey through Press Ganey. Responses are measured on a scale of 1 to 5, with 5 being the best score. Comments are also gathered from our CG-CAHPS Medical Practice Survey through Press Ganey and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.

Is this you? Edit Profile
back to top button